In addition to strongly predicting mortality in HF patients (16), IGFBP-2 has recently emerged as a novel candidate biomarker for cardiovascular risk assessment in patients with aortic stenosis who undergo transcatheter aortic valve implantation (17) and elderly men (18). The gene discussed is IGFBP2; the disease is aortic stenosis.